Olanzapine (OLZ) is an atypical antipsychotic drug and is commonly used for the treatment of schizophrenia and bipolar disorder (BD). However, recent reports indicated that this drug could exhibit cytotoxic effects on nervous and immune systems. To our knowledge, there is scarce data considering the genotoxic or oxidative damage potentials of OLZ on human lymphocyte culture system. Therefore, in this study, the genotoxic potential of OLZ (0 to 160 µM) have been evaluated in human whole blood cultures (WBCs) related to oxidative status. Sister-chromatid exchange (SCE) test was applied to estimate the DNA damage, and biochemical parameters (total antioxidant capacity [TAC] and total oxidative stress [TOS]) were examined to determine oxidative stress. Our results indicated that the tested antipsychotic drug did not induce SCEs in lymphocytes of treated cultures. However, the application of the highest OLZ concentration caused oxidative stress. It is concluded that the OLZ can be used safely, but it is necessary to consider the tissue damages that are likely to appear depending on the oxidative stress.
Al-chalabi BM, Thanoon IAJ, and Ahmed FAA ( 2009) Potential effect of olanzapine on total antioxidant status and lipid peroxidation in schizophrenic patients. Neuropsychobiology59: 8-11.
2.
Aliyazicioğlu R., Kural B., Colak M., Karahan SC, Ayvaz S., and Değer O. ( 2007) Treatment with lithium, alone or in combination with olanzapine, relieves oxidative stress but increases atherogenic lipids in bipolar disorder . Tohoku Journal Experimental Medicine213: 79-87.
3.
Bakare A., Shao L., Cui J., Young LT, and Wang JF ( 2009) Mood stabilizing drugs lamotrigine and olanzapine increase expression and activity of glutathione s-transferase in primary cultured rat cerebral cortical cells. Neuroscience Letters455: 70-73.
4.
Belhani D., Frassati D., Mégard R., Tsibiribi P., Bui-Xuan B., Tabib A., et al. (2006) Cardiac lesions induced by neuroleptic drugs in the rabbit. Experimental Toxicological Patholology57: 207-212.
5.
Brambilla G., Mattioli F., and Martelli A. ( 2007) Genotoxic and carcinogenic effects of antipsychotics and antidepressants. Toxicology261: 77-88.
6.
Cadario B. ( 2000) Olanzapine (Zyprexa): suspected serious reactions . Canadian Medical Association Journal163: 89-90.
7.
Cinkilic N., Kiyici S., Celikler S., Vatan O., Gul OO, Tuncel E., et al. (2009) Evaluation of chromosome aberrations, sister chromatid exchange and micronuclei in patients with type-1 diabetes mellitus. Mutation Research676: 1-4.
8.
Delieu JM, Horobin RW, and Duguid JK ( 2006) Formation of immature neutrophil leukocytes in schizophrenic patients treated with various antipsychotic drugs: comparisons and predictions . Journal of Psychopharmacology20: 824-828.
9.
Delieu JM, Horobin RW, and Duguid JK ( 2009) Exploring the relationship of drug-induced neutrophil immaturity & haematological toxicity to drug chemistry using quantitative structure-activity models. Medicinal Chemistry5: 7-14.
10.
Dong E., Nelson M., Grayson DR, Costa E., and Guidotti A. ( 2008) Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proceedings of National Academy of Sciences of the United States of America105: 13614-13619.
11.
Erel O. ( 2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation . Clinical Biochemistry37: 277-285.
12.
Erel O. ( 2005) A new automated colorimetric method for measuring total oxidant status. Clinical Biochemistry38: 1103-1111.
13.
Evans HJ, O’Riordan ML ( 1975) Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests. Mutation Research31: 135-148.
14.
Fiander H., Schneider Fh ( 2000) Dietary ortho phenols that induce glutathione S-transferase and increase the resistance of cells to hydrogen peroxide are potential cancer chemopreventives that act by two mechanisms: the alleviation of oxidative stress and the detoxification of mutagenic xenobiotics. Cancer Letters156: 117-124.
15.
Gajwani P., Tesar GE ( 2000) Olanzapine-induced neutropenia. Psychosomatics41: 150-151.
16.
Gardner I., Zahid N., MacCrimmon D., and Uetrecht JP ( 1998) A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes . Molecular Pharmacology6: 991-998.
17.
Gerber JE, Cawthon B. ( 2000) Overdose and death with olanzapine: two case reports . American Journal of Forensic Medicine and Pathology21: 249-251.
18.
Geyikoglu F., Turkez H. ( 2005) Protective effect of sodium selenite on genotoxicity to human whole blood cultures induced by aflatoxin B-1. Brazilian Archives of Biology and Technology48: 905-910.
19.
Heard KJ, Cleveland NR, and Krier S. ( 2009) The effect of olanzapine pretreatment on acute cocaine toxicity in mice. Clinical Toxicology47: 542-544.
20.
Lee KH, Abe S., Yanabe Y., Matsuda I., and Yoshida MC ( 1990) Superoxide-dismutase activity and chromosome damage in cultured chromosome instability syndrome cells. Mutation Research244: 251-256.
21.
Lokshin P., Dorfman P., Shoshani D., Wimmer P., Dossenbach M., and Belmaker RH ( 1999) Olanzapine treatment after clozapine induced agranulocytosis . Human Psychopharmacology: Clinical and Experimental13: 583-584.
22.
Lu Y., Meng Q., Zhang G., and Bei X. ( 2008) Clozapine-induced hepatotoxicity in rat hepatocytes by gel entrapment and monolayer culture. Toxicology In Vitro22: 1754-1760.
23.
Martins MR, Petronilho FC, Gomes KM, Dal-Pizzol F., Streck EL, and Quevedo J. ( 2008) Antipsychotic-induced oxidative stress in rat brain . Neurotoxicity Research13: 63-69.
24.
Meister A. ( 1983) Selective modification of glutathione metabolism . Science220: 472-477.
25.
Merrick TC, Felo JA, and Jenkins AJ ( 2001) Tissue distribution of olanzapine in a postmortem case . American Journal of Forensic Medicine and Pathology22: 270-274.
26.
Mishra AC, Mohanty B (2010) Effects of lactational exposure of olanzapine and risperidone on hematology and lymphoid organs histopathology: a comparative study in mice neonates. European Journal of Pharmacology634: 170-177.
27.
Muench J., Hamer AM (2010) Adverse effects of antipsychotic medications. American Family Physician81: 617-622.
28.
Ozcanli T., Erdogan A., Ozdemir S., Onen B., Ozmen M., Doksat K., et al. (2006) Severe liver enzyme elevations after three years of olanzapine treatment: a case report and review of olanzapine associated hepatotoxicity. Progress in Neuropsychopharmacology Biological Psychiatry30: 1163-1166.
29.
Oyesanmi O., Kunkel EJS, Monti DA, and Field HL ( 1999) Hematologic side effects of psychotropics. Psychosomatics40: 414-421.
30.
Ozturk O., Gumuslu S. ( 2004) Age-related changes of antioxidant enzyme activities, glutathione status and lipid peroxidation in rat erythrocytes after heat stress . Life Sciences75: 1551-1565.
31.
Patel M., Bapu C., Padh H., and Nivsarkar M. ( 2004) Olanzapine induced thrombocythemia in Sprague Dawley rats . Drug and Chemical Toxicology27: 379-387.
32.
Perticone P., Cozzi R., and Gustavino B. ( 1987) Sister chromatid exchanges induced by DNA demethylating agents persist through several cell cycles in mammalian cells. Carcinogenesis8: 1059-1063.
33.
Perry P., Wolff S. ( 1974) New Giemsa method for the differential staining of sister chromatids. Nature251: 156-158.
Ray JH ( 1984) Sister-chromatid exchange induction by sodium selenite: reduced glutathione converts Na2SeO3 to its SCE-inducing form. Mutation Research141: 49-53.
36.
Sayin A., Cosar B. ( 2006) Prolongation of clozapine-induced leukopenia with olanzapine treatment. Progress in Neuropsychopharmacology Biological Psychiatry30: 958-959.
37.
Shertzer HG, Kendig EL, Nasrallah HA, Johansson E., and Genter MB ( 2010) Protection from olanzapine-induced metabolic toxicity in mice by acetaminophen and tetrahydroindenoindole. International Journal of Obesity (accessed 12 January 2010).
38.
Singh OP, Chakraborty I., Dasgupta A., and Data S. ( 2008) A comparative study of oxidative stress and interrelationship of important antioxidants in haloperidol and olanzapine treated patients suffering from schizophrenia. Indian Journal of Psychiatry50: 171-176.
39.
Stergiou V., Bozikas VP, Garyfallos G., Nikolaidis N., Lavrentiadis G., and Fokas K. ( 2005) Olanzapine-induced leucopenia and neutropenia. Progress in Neuropsychopharmacology Biological Psychiatry29: 992-994.
40.
Tan HH, Hoppe J., and Heard K. ( 2009) A systematic review of cardiovascular effects after atypical antipsychotic medication overdose. American Journal of Emergency Medicine27: 607-616.
41.
Therman E., Susman M. ( 1993) Human chromosomes: structure, behaviour, and effects . New York: Springer.
42.
Tu CH, Yang S. ( 2002) Olanzapine-induced EDTA- Dependent pseudothrombocytopoenia . Psychosomatics43: 421-423.
43.
Vojdani A., Ghoneum M., and Choppa P. ( 1997) Minimizing cancer risk using molecular techniques: a review . Toxicology and Industrial Health13: 589-626.
44.
Waring WS, Wrate J., and Bateman DN ( 2006) Olanzapine overdose is associated with acute muscle toxicity . Human Experimental Toxicology25: 735-740.
45.
Wiklund ED, Catts VS, Catts SV, Ng TF, Whitaker NJ, Brown AJ, et al. (2010) Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target. International Journal Cancer126: 28-40.
46.
Wrighton SA, Ring BJ ( 1999) Predicting drug interactions and pharmacokinetic variability with in vitro methods: the olanzapine experience. Drug Metabolism Reviews31: 15-28.
